TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer. [electronic resource]
Producer: 20170606Description: 361-7 p. digitalISSN:- 1432-0843
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Australia
- Biliary Tract Neoplasms -- drug therapy
- CA-19-9 Antigen -- blood
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Female
- Humans
- Male
- Middle Aged
- Panitumumab
- Patient Selection
- Prospective Studies
- Proto-Oncogene Proteins p21(ras) -- genetics
- Survival Rate
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.